Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5226_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
02.09.2026
Размер:
19 Мб
Скачать
30
punch, curved endoscopic scissors, microdebrider with straight and angled attach­ments (40- and/or 60-degree attachments), monopolar suction cautery, and endo­scopic drill.
N. Ayoub and P. H. Hwang

Surgical Indications

Initial surgical indications for EMMA were focused on resection of tumors, includ­ing malignant tumors and benign but locally aggressive neoplasms (e.g., inverted papilloma) [3]. EMMA improved endoscopic access to the maxillary sinus to resect these lesions to reduce the need for a Caldwell-Luc or open maxillectomy.
The indications for EMMA have broadened over time to include inammatory disorders of the maxillary sinus. The main indications for a mega-antrostomy in a patient with chronic rhinosinusitis include recalcitrant maxillary sinusitis despite prior surgery, anticipated need to access sinus for topical therapy and surveillance, and primary or acquired mucociliary dysfunction. EMMA for CRS is most often performed as a salvage surgical intervention. However, this procedure can, in select cases, be performed during primary surgery. Primary EMMA is typically reserved for patients with sinusitis related to primary disorders of mucociliary clearance, including cystic brosis and primary ciliary dyskinesia. Less common indications for EMMA include odontogenic cysts, mucoceles, fungus balls, allergic fungal sinusitis, and mucus recirculation between an inferior meatal window and middle meatal antrostomy.

Surgical Technique (Video 3.1)

The procedure is performed endoscopically under general anesthesia. General prin­ciples of the procedure include sufcient widening of the maxillary antrostomy, mucosal preservation, avoidance of injury to the nasolacrimal duct, and preserva­tion of the anterior portion of the inferior turbinate. The initial procedure details vary depending on whether the patient had a prior maxillary antrostomy or is surgi­cally naïve (e.g., patient with CF).
If the patient is surgically naïve, the procedure begins with a traditional endo­scopic maxillary antrostomy. Uncinectomy is performed from posterior to anterior using backbiting and through-cutting instruments. A 30-degree nasal endoscope is then used to visualize the lateral nasal wall and identify the maxillary os. Once the true os is identied, it can be dilated gently with a maxillary ball probe or curved suction. A microdebrider and through-cut instruments can then be used to widen the antrostomy posteriorly.
When mega-antrostomy is being performed as revision surgery, the prior antros­tomy should be inspected with the angled endoscope, with particular attention to the os. Residual uncinate process and/or scarring that may be obstructing the ostial outow or causing recirculation are removed. Because the mega-antrostomy is a
3 Mega-antrostomy/Endoscopic Medial Maxillectomy for Recalcitrant Chronic…
31
mucosal sparing procedure, it is expected that the maxillary sinus mucosa will still direct mucus towards the natural os, even with the extended antrostomy. If not pre­viously done so, the antrostomy is extended posteriorly with through-cut forceps towards the posterior wall of the maxillary sinus.
Next, the posterior ½ to 2/3 of the inferior turbinate is resected in order to expose the inferior aspect of the medial wall of the maxillary sinus as it forms the lateral wall of the inferior meatus. Using curved endoscopic scissors, the inferior turbinate is rst transected full-thickness with a vertically oriented cut, positioning the scis­sors at the ventral aspect of the turbinate and aiming the tip of the scissors towards the maxillary ostium (Fig. 3.1). The planned incision can be marked by crimping the turbinate with a curved surgical clamp, which may reduce bleeding, although this step is not routinely used by the senior author. Next, the posterior segment of the inferior turbinate is detached from the lateral wall of the nasal cavity by using a straight endoscopic scissor to cut the attachment of the turbinate to the medial wall of the maxillary sinus (Fig. 3.2). Extension of the scissor cut posteriorly across the posterior stump of the inferior turbinate fully releases the posterior inferior turbi­nate, which is removed from the surgical eld. The nal cut across the posterior stump of the inferior turbinate often exposes the inferior turbinate artery, which should be cauterized, along with the residual turbinate stump, with monopolar suc­tion cautery to decrease the risk of postoperative epistaxis.
Next, down-biting through-cutting antral punches are used to resect the medial wall of the maxillary sinus and extend the antrostomy down to the level of the nasal oor. Some surgeons favor drilling thicker portions of the medial maxillary wall and rotating local mucosal aps to cover exposed areas of bone, but this is not routinely performed by the senior author. If additional anterior exposure is required, the mega-antrostomy can be extended anteriorly along the nasal oor using a backbit­ing forceps, remaining inferior to Hasner’s valve (Fig. 3.3). This additional anterior­inferior limb of the mega-antrostomy can be brought forward as far anteriorly as the medial maxillary buttress.
Fig. 3.1 Curved endoscopic scissors are used to resect the posterior ½ to 2/3 of the inferior turbinate. Medialization of the turbinate prior to transection can reduce the risk of injury to the lateral nasal wall and Hasner’s valve
32
Fig. 3.2 The posterior stump of the inferior turbinate is transected, which often results in bleeding from the inferior turbinate branch of the sphenopalatine artery
Fig. 3.3 After the medial wall of the maxillary sinus is resected to the oor of the nasal cavity, the antrostomy can be extended anteriorly, taking care to remain inferior to Hasner’s valve
N. Ayoub and P. H. Hwang
After securing hemostasis with electrocautery and topical vasoconstrictors, the procedure is concluded without placement of any absorbable or non-absorbable nasal packing.

Reported Outcomes

There is a growing body of literature showing the benets and overall safety of this procedure; however, prospective data is limited. There was a2020 systematic review that included two level 2 evidence studies and four level 4 studies [15].
Cho etal. showed a signicant improvement in symptoms and endoscopy scores after EMMA, with >80% of patients showing a reduction in the need for antibiotic and oral steroid use [16]. Long-term follow-up (mean 6.9years) in a subsequent paper by the same research group showed maintenance of the symptomatic benets of EMMA, with 72% of patients describing complete or signicant improvement in
3 Mega-antrostomy/Endoscopic Medial Maxillectomy for Recalcitrant Chronic…
33
symptoms and 28% a partial improvement [17]. No patient in that review described exacerbation of any sinonasal symptoms.
Wang, etal., in a retrospective analysis of 46 patients with recalcitrant maxillary sinusitis who underwent EMMA, showed a complete resolution of sinonasal symp­toms in 80% of patients over a mean 35-month follow-up period [18]. Within a subgroup of 15 patients who had undergone prior Caldwell-Luc, 73% experienced symptomatic improvement after EMMA. No patients required revision surgery. Similarly, Woodworth etal. reviewed 19 patients with chronic maxillary sinusitis, 14 of whom had undergone prior Caldwell-Luc, and showed resolution of hyper­plastic mucosa in 95% of patients after a mean 19.5-month follow-up [19]. Thulasidas etal. reported no recurrence of disease in all 24 patients who underwent EMMA over a mean follow-up of 14.6months [20].
In a review of 551 medial maxillectomies, Wong, etal. showed a 25% incidence of mucostasis 3months postoperatively, but this incidence decreased to 10.2% at the last postoperative visit, suggesting an improved rate of sustained mucostasis over time [21]. Patients in that review had a 5% incidence of revision sinus surgery after EMMA.Given the widened maxillary antrostomy, the risks of restenosis are argu­ably lower.
EMMA has also been proposed as an initial or subsequent procedure for patients with predilection for sinonasal inammatory disease [22]. In a subset of patients with cystic brosis, Virgin et al. reported signicant improvement in SNOT-22 score and Lund-Kennedy score one year after surgery [23]. The frequency of pul­monary exacerbation-associated hospital admissions also decreased in the year after surgery. There was a 9.1% reoperation rate in this group of patients with cystic brosis.
In a cadaveric study, Govindaraju, etal. showed that more extended maxillary sinus antrostomies, including EMMA, were associated with greater postoperative irrigation penetration, visualization, and instrument reach [1]. EMMA has also been shown to improve air entry into the maxillary sinus. Through computational uid dynamics modeling, Siu etal. showed a positive linear correlation between the max­illary antrostomy size and the rate of airow into the maxillary sinus [24].

Potential Complications

Potential complications specic to EMMA include bleeding from the posterior stump of the partially resected inferior turbinate, injury to the nasolacrimal duct, and paradoxical nasal obstruction (i.e., empty nose syndrome) due to partial resec­tion of the inferior turbinate [25]. However, the actual incidence of complications of EMMA is low. A systematic review by Loftus, etal. reported a total of 4 complica­tions out of 211 (1.9%) included patients. These included nasolacrimal duct obstruc­tion (n=2), epistaxis requiring return to the operating room (n=1), and hypoplastic maxillary sinus (n=1) [1921].
34
N. Ayoub and P. H. Hwang
Preservation of a portion of the anterior aspect of the inferior turbinate may decrease the incidence of certain complications. Using computational uid dynam­ics modeling, Saibene etal. found greater ow rates and uid velocities at the max­illary sinus after EMMA compared to modied EMMA with preservation of the inferior turbinate, suggesting a greater disruption in normal nasal airow dynamics after EMMA [26]. The authors postulated that this difference could contribute to the more persistent postoperative crusting and reduced nasal air conditioning seen after EMMA.Gras-Cabrerizo etal. discussed a technique to preserve the inferior turbi­nate during EMMA [27]. The authors initially make an incision at the head and body of the inferior turbinate, then perform the medial maxillectomy. At the end of the procedure, the head and body of the middle turbinate are sutured back to each other. Using acoustic rhinometry, Gras-Cabrerizo showed maintenance of normal nasal resistance with this technique.
Tips and Pearls
• Maintain the anterior 1/3 to ½ of the inferior turbinate undisturbed to decrease
the risk of empty nose syndrome.
• When performing the inferior turbinate partial resection, rst medialize the infe-
rior turbinate. This helps decrease the risk of inadvertent injury to the lateral
nasal wall and Hasner valve.
• Cauterize the posterior stump of the inferior turbinate to decrease the risk of
postoperative epistaxis from the inferior turbinate branch of the sphenopala-
tine artery.
• Perform only limited postoperative debridement of the posterior inferior turbi-
nate stump at the rst postoperative visit, as early removal of the crust may lead
to epistaxis.
• If the nasolacrimal duct is injured, a complete inferior transection of the duct
decreases the risk of postoperative nasolacrimal duct stenosis when compared to
incision without complete transection.
• The surgeon can consider upfront EMMA for patients with chronic ciliary dys-
function (e.g., cystic brosis or primary ciliary dyskinesia).

References

1. Govindaraju R, Prepageran N.The role of endoscopic medial maxillectomy in sinus disease. Curr Opin Otolaryngol Head Neck Surg. 2021;29(1):1–8.
2. Ashman A, Psaltis AJ, Wormald PJ, etal. Extended endoscopic approaches to the maxillary sinus. J Laryngol Otol. 2020;134:473–80.
3. Kamel RH.Transnasal endoscopic medial maxillectomy in inverted papilloma. Laryngoscope. 1995;105:847–53.
4. Tepedino MS, Miotello Ferrao AC, Morais Higa HC, etal. Reversible endoscopic medial max­illectomy: endonasal approach to diseases of the maxillary sinus. Int Arch Otorhinolaryngol. 2020;24:E247–52.
3 Mega-antrostomy/Endoscopic Medial Maxillectomy for Recalcitrant Chronic…
5. Coleman JR Jr, Duncavage JA.Extended middle meatal antrostomy: the treatment of circular ow. Laryngoscope. 1996;106:1214–7.
6. Nakayama T, Asaka D, Okushi T, etal. Endoscopic medial maxillectomy with preservation of inferior turbinate and nasolacrimal duct. Am J Rhinol Allergy. 2012;26:405–8.
7. Sessions RB, Humphreys DH. Technical modications of the medial maxillectomy. Arch Otolaryngol. 1983;109:575–7.
8. Ghosh A, Pal S, Srivastava A, etal. Modication of endoscopic medial maxillectomy: a novel approach for inverted papilloma of the maxillary sinus. J Laryngol Otol. 2015;129:159–63.
9. Jurado-Ramos A, Jodas JG, Romero FR, etal. Endoscopic medial maxillectomy as a proce­dure of choice to treat inverted papillomas. Acta Otolaryngol. 2009;129:1018–25.
10. Kennedy DW, Adappa ND.Endoscopic maxillary antrostomy: not just a simple procedure. Laryngoscope. 2011;121(10):2142–5.
11. Thamboo A, Ayoub N, Maul X, etal. The inferior turbinate: role in normal respiration and airway obstruction. Curr Otorhinolaryngol Rep. 2021;9:383–8.
12. Chastain JB, Cooper MH, Sindwani R.The maxillary line: anatomic characterization and clin­ical utility of an important surgical landmark. Laryngoscope. 2005;115(6):990–2.
13. Greater palatine canal: Ayoub N, Thamboo A, Hwang PH, Walgama ES. Radioanatomic Study of the Greater Palatine Canal relevant to endoscopic endonasal surgical landmarks. Otolaryngol Head Neck Surg 2017;157(4):731–736.
14. Iwanaga J, Wilson C, Lachkar S, Tomaszewski KA, Walocha JA, Tubbs RS.Clinical anatomy of the maxillary sinus: application to sinus oor augmentation. Anat Cell Biol. 2019;52(1):17–24.
15. Loftus CA, Yoo F, Desiato VM, Schlosser RJ, Soler ZM.Treatment of recalcitrant maxillary sinusitis with endoscopic modied medial maxillectomy: a systematic review of safety and efcacy. Am J Rhinol Allergy. 2020;34(1):127–33.
16. Cho DY, Hwang PH.Results of endoscopic maxillary mega-antrostomy in recalcitrant maxil­lary sinusitis. Am J Rhinol. 2008;22:658–62.
17. Costa ML, Psaltis AJ, Nayak JV, Hwang PH. Long-term outcomes of endoscopic maxil­lary mega-antrostomy for refractory chronic maxillary sinusitis. Int Forum Allergy Rhinol. 2015;5:60–5.
18. Wang EW, etal. Modied endoscopic medial maxillectomy for recalcitrant chronic maxillary sinusitis. Int Forum Allergy Rhinol. 2011;1(6):493–7.
19. Woodworth BA, Parker RO, Schlosser RJ.Modied endoscopic medial maxillectomy for chronic maxillary sinusitis. Am J Rhinol. 2006;20:317–9.
20. Thulasidas P, Vaidyanathan V.Role of modied endoscopic medial maxillectomy in persistent chronic maxillary sinusitis. Int Arch Otorhinolaryngol. 2014;18:159–64.
21. Wong EH, Cavada MN, Orgain CA, et al. The modied medial maxillectomy as a radi­cal or extended,-yet still functional,-technique in sinus surgery. Am J Rhinol Allergy. 2023;37(4):476–84.
22. Illing EA, Woodworth BA.Management of the upper airway in cystic brosis. Curr Opin Pulm Med. 2014;20(6):623–31.
23. Virgin FW, etal. Extensive surgical and comprehensive postoperative medical management for cystic brosis chronic rhinosinusitis. Am J Rhinol Allergy. 2012;26(1):70–5.
24. Siu J, Dong J, Inthavong K, Shang Y, Douglas RG.Quantication of airow in the sinuses fol­lowing functional endoscopic sinus surgery. Rhinology. 2020;58(3):257–65.
25. Talmadge J, Nayak JV, Yao W, Citardi MJ.Management of postsurgical empty nose syndrome. Facial Plast Surg Clin North Am. 2019;27(4):465–75.
26. Saibene AM, Felisati G, Pipolo C, Bulfamante AM, Quadrio M, Covello V.Partial preservation of the inferior turbinate in endoscopic medial maxillectomy: a computational uid dynamics study. Am J Rhinol Allergy. 2020;34(3):409–16.
27. Gras-Cabrerizo JR, Martel-Martin M, Montserrat-Gili JR, et al. Endoscopic medial maxil­lectomy with preservation of inferior turbinate: assessing results by acoustic rhinometry. J Craniofac Surg. 2019;30(4):996–9.
35

Endoscopic Denker’s Approach

JustinP.McCormick andJivianneT.Lee
Key Points
• Chronic rhinosinusitis is a complex inammatory disease with a surgical revi-
sion rate of up to 15–20%.
• The modied endoscopic Denker’s approach is classically described for address-
ing tumors involving the anterior or lateral wall of the maxillary sinus, but also is an option for the management of recalcitrant chronic rhinosinusitis.
• This surgical technique utilizes an endonasal maxillotomy without the need for
separate external incisions.
• The modied endoscopic Denker’s approach allows for complete exposure of the
anterior and medial maxilla and may be a useful adjunct procedure in patients with severe recalcitrant chronic rhinosinusitis.
4
Supplementary Information The online version contains supplementary material available at
https://doi.org/10.1007/978- 3- 031- 89191- 5_4.
J. P. McCormick Department of Head and Neck Surgery and Communication Sciences, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA
J. T. Lee ( Division of Rhinology & Endoscopic Sinus and Skull Base Surgery, Department of Head and Neck Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA e-mail: JTLee@mednet.ucla.edu
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2025 J. T. Lee etal. (eds.), Advances in Surgical and Medical Interventions for Recalcitrant Chronic Rhinosinusitis,
https://doi.org/10.1007/978-3-031-89191-5_4
*)
37
38
J. P. McCormick and J. T. Lee

Background

Chronic rhinosinusitis (CRS) is an inammatory disease of the paranasal sinuses which causes symptoms of nasal obstruction, thick nasal drainage, smell dysfunc­tion, and facial pain or pressure for a time period of greater than 12weeks [1]. The management of CRS begins with medical therapy which can include a combina­tion of large volume saline irrigations, intranasal corticosteroids, oral corticoste­roids, and/or antibiotics depending on the phenotype/endotype of the CRS, typically for a 3–4week period [1]. The response rate to medical therapy alone is quite varied and has been reported to be 37.5–90% [2, 3]. When patients fail to respond to appropriate medical therapy, which can be dened as persistence of symptoms with ndings of sinonasal inammation on radiography or endoscopy, they can be offered sinus surgery.
The goals of endoscopic sinus surgery (ESS) have been similar since its intro­duction in the 1980s. ESS seeks to reestablish sinus ventilation and improve access for delivery of topical medications [4]. Despite adequate ESS and post-operative medical management, a subset of patients will develop recurrent or refractory symp­toms. Several large database studies have reported overall revision rates after ESS of 15–20% [57]. Reasons for primary surgical failure have been suggested to include postoperative scarring, neo-osteogenesis, inadequate postoperative man­agement, or incomplete primary surgical extirpation. After initial surgical failure, extended approaches may be required to improve access for long-term topical thera­pies. The maxillary sinus has several extended approaches that may be employed to address recalcitrant chronic maxillary sinusitis [8].
A standard middle meatal maxillary antrostomy involves resecting the uncinate process to expose the natural ostium of the maxillary sinus, followed by widening of the natural ostium. The appropriate maxillary ostium size is a topic of debate; however, it is the preference of the authors to perform a wide maxillary antrostomy during primary ESS to facilitate in-ofce monitoring and management. The primary maxillary antrostomy may involve extending the natural ostium from the nasolacri­mal duct anteriorly to the posterior wall of the maxillary sinus, and opening the sinus superiorly to the orbital oor and inferiorly to the attachment of the inferior turbinate. There are several extended surgical approaches to the maxillary sinus. The endoscopic maxillary mega-antrostomy involves resection of the mid-portion of the inferior turbinate, and extends the antrostomy inferiorly to the oor of the nasal cavity [9]. The modied endoscopic medial maxillectomy, which involves more aggressive resection of the inferior turbinate and extends the antrostomy ante­rior and inferior to Hasner’s valve to expose the more anterior aspect of the maxil­lary sinus. The Caldwell-Luc approach utilizes an intraoral incision to perform an anterior maxillotomy allowing access to the far anterior-lateral aspect of the maxil­lary sinus [10]. Recently, an endoscopic modication to the standard Denker’s approach has been described to address tumors of the maxillary sinus; however, it may also be adapted to address recalcitrant maxillary sinusitis, as the standard Denker’s approach has been used previously [11].
4 Endoscopic Denker’s Approach
39

Surgical Technique

The standard Denker’s approach involves a sublabial incision that exposes a wide area of the anterior maxillary wall. An anterior maxillotomy is then performed and extended laterally to the infraorbital foramen and superiorly to the orbital rim. The lateral nasal wall is then incised and resected to the oor of the nasal cavity, includ­ing resection of the inferior turbinate. This allows exposure of the ethmoid sinuses where complete sphenoethmoidectomy can be performed, and the middle turbinate is resected. The nasolacrimal duct is then identied and sharply transected near the lacrimal sac. Once the sinuses have been widely opened, forceps are used to the remove the mucosa of sinus cavities [12].
Recently the Denker’s approach has been modied to allow for similar access via a completely endoscopic approach (Table4.1) [11]. An endoscopic medial maxil­lectomy is performed. Electrocautery with a guarded needle tip [Megadyne, Draper, UT] is used to make a mucosal incision at the junction of the nasal oor and lateral nasal wall through the periosteum. The incision is then extended along the head of the inferior turbinate at the edge of the pyriform aperture. Then, a subperiosteal dis­section is performed with a suction freer elevator [Olympus ENT, Southborough, MA] to expose the anterior aspect of the maxilla, the infraorbital foramen, and its neurovascular bundle. A high-speed drill is utilized to create a bony window into the anterior wall of the maxillary sinus, taking care to stay inferior to the infraorbital foramen and preserve the anterior superior alveolar nerve. Further drilling of the pyriform aperture is performed to connect the anterior maxillotomy to the inferior portion of the endoscopic medial maxillectomy. This exposure allows access to the anterior-lateral, and anterior-inferior medial portion of the maxillary sinus (Fig.4.1). At the end of the procedure, the nasolacrimal duct is identied and is sharply obliquely transected to prevent stenosis (Video 4.1).
Table 4.1 Steps to perform the modied endoscopic Denker’s approach
Step 1 Perform an endoscopic medial maxillectomy by completing a standard
maxillary antrostomy and then excising the middle portion of the inferior turbinate allowing the medial maxillary sinus wall to be resected to the nasal oor.
Step 2 Using monopolar electrocautery, make a mucosal incision at the pyriform
aperture extending from the oor of the nose to the superior portion of the inferior turbinate
Step 3 Using a suction elevator, dissect in a subperiosteal plane along the anterior
aspect of the maxilla until the infraorbital neurovascular bundle is identied
Step 4 A high speed drill is used to create a bony window into the anterior wall of
the maxillary sinus, taking care to stay inferior to the infraorbital foramen
Step 5 Further drilling of the medial aspect of the pyriform aperture is performed
to connect the anterior maxillotomy to the inferior portion of the endoscopic medial maxillectomy
Step 6 The nasolacrimal duct is then identied within the mucosal of the lateral
nasal wall, and the lumen is cut obliquely to prevent stenosis
(Fig. 4.2)
(Fig. 4.3)
(Fig. 4.4)
(Fig. 4.5)
(Fig. 4.6)
40
Fig. 4.1 Completion of the endoscopic Denker’s approach allows for full visualization of all walls of the maxillary sinus
Fig. 4.2 To begin the endoscopic Denker’s approach, a mucosal incision is made with a monopolar cautery at the pyriform aperture
J. P. McCormick and J. T. Lee
Role oftheDenker’s Approach inRecalcitrant CRS
The Denker’s approach for treatment-resistant maxillary sinusitis was rst reported in the 1990s by a group in the Netherlands. Kerrebijn etal [12] reviewed their series of 56 patients with treatment resistant chronic rhinosinusitis with nasal polyps (CRSwNP). All patients underwent thestandard Denker’s approach and had at least 36months offollow-up. Long term results after radical surgery demonstrated reso­lution of nasal discharge in 82% of patients, restored sense of smell in 89% of patients, and resolution of headaches in 87% of patients. Despite these positive